Statins as a newly recognized type of immunomodulator.

Kwak, Brenda, Mulhaupt, Flore, Myit, Samir, Mach, François·2000·Nature Medicine

Cited by (1,001)

Items 601–700 of 1,001

  1. Treatment of experimental autoimmune uveoretinitis with atorvastatin and lovastatin
    Hideo Kohno, Tsutomu Sakai, Saburô Saitô, Kiichiro Okano, Kenji Kitahara · 2007 · Experimental Eye Research
  2. Simvastatin inhibits the migration and adhesion of monocytic cells and disorganizes the cytoskeleton of activated endothelial cells
    Mayte Pozo, Rosario de Nicolás, Jesús Egido, Jesús González-Cabrero · 2006 · European Journal of Pharmacology
  3. HMG-CoA Reductase Inhibitors in Chronic Heart Failure
    Ulrich Laufs, Florian Custodis, Michael B�hm · 2006 · Drugs
  4. Statins in Mitigating Anticancer Treatment-Related Cardiovascular Disease
    Rong Jiang, Lian Lou, Wen Shi, Yuxiao Chen, Zhaoming Fu, Shuo Liu, Thida Sok, Zhihang Li, Xuan Zhang, Jian Yang · 2024 · International Journal of Molecular Sciences
  5. Predictors of high sensitivity C-reactive protein levels in patients with systemic lupus erythematosus
    S-S. Lee, Sonal Singh, LS Magder, Michelle Petri · 2008 · Lupus
  6. Early detection of cardiac allograft vasculopathy using highly automated 3-dimensional optical coherence tomography analysis
    Michal Pazderník, Zhi Chen, Helena Bedáňová, Josef Kautzner, Vojtěch Melenovský, V. Karmazin, Ivan Málek, Aleš Tomášek, Eva Ozábalová, Jan Krejčí et al. · 2018 · The Journal of Heart and Lung Transplantation
  7. Statins, metformin, proprotein-convertase-subtilisin-kexin type-9 (PCSK9) inhibitors and sex hormones: Immunomodulatory properties?
    Christian A. Koch, Siegfried Krabbe, Bernd Hehmke · 2018 · Reviews in Endocrine and Metabolic Disorders
  8. Statins, Nitric Oxide and Neovascularization
    Feng Ma, Zhongchao Han · 2006 · Cardiovascular Drug Reviews
  9. Nonlipid-lowering effects of statins
    Sajoscha A. Sorrentino, Ulf Landmesser · 2005 · Current Treatment Options in Cardiovascular Medicine
  10. Pravastatin induces thrombomodulin expression in TNFα‐treated human aortic endothelial cells by inhibiting Rac1 and Cdc42 translocation and activity
    Shing‐Jong Lin, Yung‐Hsiang Chen, Feng‐Yen Lin, Li‐Yuan Hsieh, Shu‐Huei Wang, Chia‐Ying Lin, Yu‐Chieh Wang, Hung‐Hai Ku, Jaw‐Wen Chen, Yuh‐Lien Chen · 2007 · Journal of Cellular Biochemistry
  11. Giant cell arteritis: beyond temporal artery biopsy and steroids
    Jem V. Ninan, Susan Lester, Catherine Louise Hill · 2017 · Internal Medicine Journal
  12. Myeloid HMG-CoA (3-Hydroxy-3-Methylglutaryl-Coenzyme A) Reductase Determines Atherosclerosis by Modulating Migration of Macrophages
    Kent Sakai, Shuichi Nagashima, Tetsuji Wakabayashi, Bayasgalan Tumenbayar, Hiroko Hayakawa, Morisada Hayakawa, Tadayoshi Karasawa, Ken Ohashi, Hisataka Yamazaki, Akihito Takei et al. · 2018 · Arteriosclerosis Thrombosis and Vascular Biology
  13. IL-1β and Statin Treatment in Patients with Myocardial Infarction and Diabetic Cardiomyopathy
    Luca Liberale, Federico Carbone, Giovanni Guido Camici, Fabrizio Montecucco · 2019 · Journal of Clinical Medicine
  14. Statins: immunomodulators for autoimmune rheumatic disease?
    Elizabeth C. Jury, Michael R. Ehrenstein · 2005 · Lupus
  15. Atherosclerosis and connective tissue diseases
    Olivier Meyer · 2001 · Joint Bone Spine
  16. Marine Polyhydroxynaphthoquinone, Echinochrome A: Prevention of Atherosclerotic Inflammation and Probable Molecular Targets
    A. A. Artyukov, Elena Zelepuga, Л. Н. Богданович, Лупач Наталья Михайловна, Vyacheslav L. Novikov, Tatyana A. Rutckova, E. P. Kozlovskaya · 2020 · Journal of Clinical Medicine
  17. Liposomal Simvastatin Attenuates Neointimal Hyperplasia in Rats
    Eyal Afergan, Meital Ben-David-Naim, Hila Epstein-Barash, Nickolay Koroukhov, Dalia Gilhar, Keren Rohekar, Haim D Danenberg, Gershon Golomb · 2010 · The AAPS Journal
  18. Simvastatin and oseltamivir combination therapy does not improve the effectiveness of oseltamivir alone following highly pathogenic avian H5N1 influenza virus infection in mice
    Jessica A. Belser, Kristy J. Szretter, Jacqueline M. Katz, Terrence M. Tumpey · 2013 · Virology
  19. Atorvastatin Down-Regulates the Primate Cellular Response to Porcine Aortic Endothelial Cells In Vitro
    Mohamed B. Ezzelarab, Daniel Welchons, Corine Torres, Hidetaka Hara, Cassandra E. Long, Peter Yeh, David Ayares, David K. C. Cooper · 2008 · Transplantation
  20. Statin use and its effect on all‐cause mortality of melanoma patients: a population‐based Dutch cohort study
    Elisabeth Livingstone, Loes M. Hollestein, Myrthe P. P. van Herk‐Sukel, Lonneke Veronique van de Poll-Franse, Arjen Joosse, Bastian Schilling, Tamar E. C. Nijsten, Dirk Schadendorf, Esther de Vries · 2014 · Cancer Medicine
  21. Regulation of IL-17 in atherosclerosis and related autoimmunity
    Heeju Ryu, Yeonseok Chung · 2015 · Cytokine
  22. Effect of Oral Atorvastatin on CD4+CD25+ Regulatory T Cells, FoxP3 Expression, and Prognosis in Patients With ST-Segment Elevated Myocardial Infarction Before Primary Percutaneous Coronary Intervention
    Dan Zhang, Shaoqin Wang, Yuqing Guan, Lei Wang, Wenzhi Xie, Nan Li, Peng Zhao, Guohai Su · 2011 · Journal of Cardiovascular Pharmacology
  23. Autoinflammatory syndromes: diagnosis and management
    Sara De Sanctis, Manuela Nozzi, Marianna Del Torto, Alessandra Scardapane, Stefania Gaspari, Giuseppina de Michele, Luciana Breda, Francesco Chiarelli · 2010 · The Italian Journal of Pediatrics/Italian journal of pediatrics
  24. Opposite effects of simvastatin on the bactericidal and inflammatory response of macrophages to opsonized S. aureus
    Daniela Benati, Micol Ferro, Maria Teresa Savino, Cristina Ulivieri, Ebe Schiavo, Annalisa Nuccitelli, Franco Laghi Pasini, Cosima T. Baldari · 2009 · Journal of Leukocyte Biology
  25. Effects of commonly used medications on bone tissue mineralisation in SaOS-2 human bone cell line
    Moshe Salai, Dalia Sömjen, Roy Gigi, O. Yakobson, Sara Katzburg, Oleg Dolkart · 2013 · The Bone & Joint Journal
  26. Engineered nanoparticles for the detection, treatment and prevention of atherosclerosis: how close are we?
    Luong T. H. Nguyen, Aristo Muktabar, Jinkai Tang, Vinayak P. Dravid, Colby Shad Thaxton, Subbu S. Venkatraman, Kee Woei Ng · 2017 · Drug Discovery Today
  27. A combination of proteasome inhibitors and antibiotics prevents lethality in a septic shock model
    Julia C Reis, Xiaoyu Tan, Rongjie Yang, Cheryl Elizabeth Rockwell, Christopher J. Papasian, Stefanie N. Vogel, David C. Morrison, Asaf A. Qureshi, Nilofer Qureshi · 2008 · Innate Immunity
  28. Role for protein geranylgeranylation in adult T-cell leukemia cell survival
    Mizuho Nonaka, Shin Uota, Yasunori Saitoh, Mayumi M. Takahashi, Haruyo Sugimoto, Tohti Amet, Ayako Arai, Osamu Miura, Naoki Yamamoto, Shoji Yamaoka · 2008 · Experimental Cell Research
  29. Effect of atorvastatin on TH1 and TH2 cytokine secreting cells during T cell activation and differentiation
    William R. Coward, Sek C. Chow · 2006 · Atherosclerosis
  30. Oral Disease-Modifying Treatments for Multiple Sclerosis
    Bernd C. Kieseier, Heinz Wiendl · 2007 · CNS Drugs
  31. Putative mechanisms of action of statins in multiple sclerosis – comparison to interferon-β and glatiramer acetate
    Oliver Neuhaus, Olaf Stüve, Juan J. Archelos, Hans-Peter Hartung · 2005 · Journal of the Neurological Sciences
  32. Regulatory impact of statins on macrophage polarization: mechanistic and therapeutic implications
    Mahvash Sadeghi, Shaho Khayati, Sajad Dehnavi, Wael A. Almahmeed, Vasily N Sukhorukovi, Amirhossein Sahebkar · 2024 · Journal of Pharmacy and Pharmacology
  33. Down regulation of CD38 activation markers by atorvastatin in HIV patients with undetectable viral load
    Stéphane De Wit, Marc Delforge, Coca Necsoi, Nathan Clumeck · 2011 · AIDS
  34. Monocyte-mediated drug delivery systems for the treatment of cardiovascular diseases
    Gil Aizik, Etty Grad, Gershon Golomb · 2017 · Drug Delivery and Translational Research
  35. Controlled release of simvastatin from biodegradable hydrogels promotes odontoblastic differentiation
    Atsuko Miyazawa, Tomonori Matsuno, Kazunari Asano, Yasuhiko Tabata, Tazuko Satoh · 2015 · Dental Materials Journal
  36. Is there an anti‐inflammatory effect of statins in rheumatoid arthritis? Analysis of a large routinely collected claims database
    Sara Lodi, Stephen J. W. Evans, P. Egger, James Robert Carpenter · 2009 · British Journal of Clinical Pharmacology
  37. Residual Beta Cell Function in Newly Diagnosed Type 1 Diabetes after Treatment with Atorvastatin: The Randomized DIATOR Trial
    Stéphan Martin, Christian Herder, Nanette Cathrin Schloot, Wolfgang Köenig, Tim Heise, Lutz Heinemann, Hubert Kolb, on behalf of the DIATOR Study Group · 2011 · PLoS ONE
  38. Statin Use Is Associated with Reduced Risk of Haematological Malignancies: Evidence from a Meta-Analysis
    Yi Xiao, Wei Jia, Yin Jin, Shang Zhen · 2014 · PLoS ONE
  39. Regulation of Suppressors of Cytokine Signaling as a Therapeutic Approach in Autoimmune Diseases, with an Emphasis on Multiple Sclerosis
    Vinod S. Ramgolam, Silva Markovic‐Plese · 2011 · Journal of Signal Transduction
  40. Therapeutic potential of statins in multiple sclerosis: immune modulation, neuroprotection and neurorepair
    Silva Markovic‐Plese, Avtar K Singh, Inderjit Singh · 2008 · Future Neurology
  41. Statins as anti-inflammatory agents: A potential therapeutic role in sight-threatening non-infectious uveitis
    Rose M. Gilbert, Ahmed Al-Janabi, Oren Tomkins‐Netzer, Susan Lightman · 2017 · Porto Biomedical Journal
  42. ‘Statins in retinal disease’
    Ahmed Al-Janabi, Susan Lightman, Oren Tomkins‐Netzer · 2018 · Eye
  43. Immunometabolism and Pulmonary Infections: Implications for Protective Immune Responses and Host-Directed Therapies
    Martin Rao, Ernest Dodoo, Alimuddin I. Zumla, Markus J. Maeurer · 2019 · Frontiers in Microbiology
  44. HMG CoA reductase inhibitors (statins) to treat Epstein–Barr virus-driven lymphoma
    Jeffrey I. Cohen · 2005 · British Journal of Cancer
  45. Induced Neuroprotection Independently From PrPSc Accumulation in a Mouse Model for Prion Disease Treated With Simvastatin
    Yaron Haviv, Dana Avrahami, Haim Ovadia, Tamir Ben‐Hur, Ruth Gabizon, Ronit Sharon · 2008 · Archives of Neurology
  46. Effect of interferon-β and atorvastatin on Th1/Th2 cytokines in multiple sclerosis
    Johann Sellner, Isabell Greeve, Oliver Findling, Christian P. Kamm, Carsten Minten, Britta Engelhardt, Denis Grandgirard, Stephen L. Leib, Heinrich Paul Mattle · 2008 · Neurochemistry International
  47. Drug Insight: using statins to treat neuroinflammatory disease
    Martin S. Weber, Thomas Prod’homme, Lawrence Steinman, Scott S. Zamvil · 2005 · Nature Clinical Practice Neurology
  48. SARS-CoV-2 infection and SLE: endothelial dysfunction, atherosclerosis, and thrombosis
    Wojciech Płazak, Leszek Drabik · 2023 · Clinical Rheumatology
  49. Replicating predictive serum correlates of greater translocator protein distribution volume in brain
    Sophia Attwells, Elaine Setiawan, Alan A. Wilson, Pablo Rusjan, Laura Miler, Cynthia Xu, Celeste Hutton, Muhammad Ishrat Husain, Stephen J. Kish, Neil Vasdev et al. · 2019 · Neuropsychopharmacology
  50. Targeting IL‐10, ZO‐1 gene expression and IL‐6/STAT‐3 trans‐signaling by a combination of atorvastatin and mesalazine to enhance anti‐inflammatory effects and attenuates progression of oxazolone‐induced colitis
    Nageh Ahmed El‐Mahdy, Magda El‐Sayed El‐Sayad, Aya Hassan El-Kadem, Sally El-Sayed Abu-Risha · 2020 · Fundamental and Clinical Pharmacology
  51. Usefulness of targeting lymphocyte Kv1.3-channels in the treatment of respiratory diseases
    Itsuro Kazama, Tsutomu Tamada, Masahiro Tachi · 2015 · Inflammation Research
  52. Therapeutic Approaches to Multiple Sclerosis
    Jochen C. Ulzheimer, Sven Guenther Meuth, Stefan Bittner, Christoph Kleinschnitz, Bernd C. Kieseier, Heinz Wiendl · 2010 · BioDrugs
  53. Immunomodulatory effects of statins and autoimmune rheumatic diseases: Novel intracellular mechanism involved
    Antonio G. Tristano, Kathy Fuller · 2006 · International Immunopharmacology
  54. Statin Therapy for Vascular Failure
    Teruo Inoue, Koichi Node · 2007 · Cardiovascular Drugs and Therapy
  55. Simvastatin suppresses the differentiation of C2C12 myoblast cells via a Rac pathway
    Tomomi T. Baba, Takayuki Nemoto, Toshihiro Miyazaki, Shinichiro Oida · 2008 · Journal of Muscle Research and Cell Motility
  56. Immunosuppressive effects of statins
    François Mach · 2002 · Atherosclerosis Supplements
  57. Agents targeting inflammation in heart failure
    Lars Lysgaard Gullestad, JOHN K. KJEKSHUS, Jan Kristian Damås, Thor Ueland, Arne Yndestad, Pål Aukrust · 2005 · Expert Opinion on Investigational Drugs
  58. Amyloid inhibitors and Alzheimer's disease.
    Weiming Xia · 2003 · PubMed
  59. Topical simvastatin enhances tissue regeneration in full-thickness skin wounds in rat models.
    Mahsima Khoshneviszadeh, Soheil Ashkani‐Esfahani, Mohammad Reza Namazi, Ali Noorafshan, Bita Geramizadeh, Ramin Miri · 2014 · Europe PMC (PubMed Central)
  60. Improved Preservation of Residual Beta Cell Function by Atorvastatin in Patients with Recent Onset Type 1 Diabetes and High CRP Levels (DIATOR Trial)
    Alexander Strom, Hubert Kolb, Stéphan Martin, Christian Herder, Marie‐Christine Simon, Wolfgang Köenig, Tim Heise, Lutz Heinemann, Michael Roden, Nanette Cathrin Schloot et al. · 2012 · PLoS ONE
  61. Immunosuppressive therapy in allograft transplantation: from novel insights and strategies to tolerance and challenges
    Ammar Ebrahimi, Seyed Ahmad Hosseini, Fakher Rahim · 2014 · Central European Journal of Immunology
  62. Pravastatin Promotes Endothelial Colony-Forming Cell Function, Angiogenic Signaling and Protein Expression In Vitro
    Nadia Meyer, Lars Brodowski, Katja Richter, Constantin Sylvius von Kaisenberg, Bianca Schröder‐Heurich, Frauke von Versen‐Höynck · 2021 · Journal of Clinical Medicine
  63. Cyclosporine A and Tacrolimus Induce Functional Impairment and Inflammatory Reactions in Endothelial Progenitor Cells
    Nadia Meyer, Lars Brodowski, Constantin von Kaisenberg, Bianca Schröder‐Heurich, Frauke von Versen‐Höynck · 2021 · International Journal of Molecular Sciences
  64. Associations of statin use with the onset and progression of open-angle glaucoma: A systematic review and meta-analysis
    Yixiong Yuan, Ruilin Xiong, Yi Wu, Jason James Ha, Wei Wang, Xiaotong Han, Mingguang He · 2022 · EClinicalMedicine
  65. Targeting Inflammation as a Therapeutic Strategy in Accelerated Atherosclerosis in Rheumatoid Arthritis
    Louise E. Full, Claudia Gianini Monaco · 2010 · Cardiovascular Therapeutics
  66. Atorvastatin effect on systemic lupus erythematosus disease activity: a double-blind randomized clinical trial
    Alimohammad Fatemi, Mahdi Moosavi, Zahra Sayedbonakdar, Ziba Farajzadegan, Mehdi Kazemi, Abbas Smiley · 2014 · Clinical Rheumatology
  67. Fluvastatin inhibits mast cell degranulation without changing the cytoplasmic Ca2+ level
    Masanori Fujimoto, Tatsuya Oka, Takahisa Murata, Masatoshi Hori, Hiroshi Ozaki · 2008 · European Journal of Pharmacology
  68. Atorvastatin therapy reduces interferon-regulated chemokine CXCL9 plasma levels in patients with systemic lupus erythematosus
    G.A. Ferreira, Antônio Lúcio Teixeira, Emília Inoue Sato · 2010 · Lupus
  69. MHC2TA promoter polymorphism (-168*G/A, rs3087456) is not associated with susceptibility to rheumatoid arthritis in British Caucasian rheumatoid arthritis patients
    Pille Harrison, J J Pointon, C. Farrar, Alice Harin, B P Wordsworth · 2006 · Lara D. Veeken
  70. Simvastatin and fluvastatin reduce interleukin-6 and interleukin-8 lipopolysaccharide (LPS) stimulated production by isolated human monocytes from chronic kidney disease patients
    Emanuela Mantuano, Samuele Santi, Cristina Filippi, Giovanni Manca-Rizza, Sabrina Paoletti, Cristina Consani, Luca Giovannini, Gianfranco Tramonti, Angelo Carpi, Vincenzo Panichi · 2007 · Biomedicine & Pharmacotherapy
  71. Efficacy and safety of fluvastatin therapy for hypercholesterolemia after heart transplantation
    Brian P O'Rourke, Mahmoud Barbir, Andrew G Mitchell, Magdi Habib Yacoub, Nicholas Robert Banner · 2004 · International Journal of Cardiology
  72. Potential antiinflammatory and immunomodulatory effects of statins in rheumatologic therapy
    Claire Arnaud, François Mach · 2006 · Arthritis & Rheumatism
  73. Comparative Protective Effect of Hawthorn Berry Hydroalcoholic Extract, Atorvastatin, and Mesalamine on Experimentally Induced Colitis in Rats
    Hassan Malekinejad, Vahid Shafiei‐Irannejad, Rahim Hobbenaghi, Seyed Hamed Tabatabaie, Seyed-Mehdi Moshtaghion · 2013 · Journal of Medicinal Food
  74. Evaluation of atorvastatin and simvastatin for treatment of multiple sclerosis
    Oliver Neuhaus, Hans‐Peter Hartung · 2007 · Expert Review of Neurotherapeutics
  75. The use of statins in acute coronary syndromes: The mechanisms behind the outcomes
    Juan Carlos Plana, Peter H. Jones · 2001 · Current Atherosclerosis Reports
  76. Potential Effect of Statins on Mycobacterium tuberculosis Infection
    Paola del Carmen Guerra-de-Blas, Pedro Torres‐González, Miriam Bobadilla-del-Valle, Isabel Sada‐Ovalle, Alfredo Ponce‐de‐León, José Sifuentes‐Osornio · 2018 · Journal of Immunology Research
  77. Immunomodulation in Heart Failure with Preserved Ejection Fraction: Current State and Future Perspectives
    Elise L. Kessler, Marish I.F.J. Oerlemans, Patricia van den Hoogen, Carmen Yap, Joost P. G. Sluijter, Saskia C.A. de Jager · 2020 · Journal of Cardiovascular Translational Research
  78. Developing vaccines for an aging population
    STEVEN B. BLACK, Ennio De Gregorio, Rino Rappuoli · 2015 · Science Translational Medicine
  79. Increased incidence of Merkel cell carcinoma among younger statin users
    Helka Sahi, Virve Koljonen, Tom Böhling, Pertti J. Neuvonen, Harri Vainio, Anne Lamminpää, Pentti Kyyrönen, ­Eero Pukkala · 2012 · Cancer Epidemiology
  80. Readapting the adaptive immune response – therapeutic strategies for atherosclerosis
    Andrew P Sage, Ziad Mallat · 2017 · British Journal of Pharmacology
  81. Statin Therapy Is Associated with Reduced Risk of Peptic Ulcer Disease in the Taiwanese Population
    Chun‐Jung Lin, Wei-Chih Liao, Yu-An Chen, Hwai‐Jeng Lin, Chun‐Lung Feng, Cheng‐Li Lin, Ying-Ju Lin, Min-Chuan Kao, Mei-Zi Huang, Chih‐Ho Lai et al. · 2017 · Frontiers in Pharmacology
  82. Prevention of Hepatocellular Carcinoma by Statins: Clinical Evidence and Plausible Mechanisms
    Gyuri Kim, Eun Seok Kang · 2019 · Seminars in Liver Disease
  83. Management of Hyperlipidaemia Associated with Heart Transplantation
    Klaus Wenke · 2004 · Drugs
  84. The statins - therapeutic diversity in renal disease?
    Justin Charles Mason · 2004 · Current Opinion in Nephrology & Hypertension
  85. Statins as emerging treatments for asthma and chronic obstructive pulmonary disease
    Garry M. Walsh · 2008 · Expert Review of Respiratory Medicine
  86. In-vivo evaluation of tissue scaffolds containing simvastatin loaded nanostructured lipid carriers and mesenchymal stem cells in diabetic wound healing
    Dilara Örgül, Hakan Eroğlu, Meral Tiryaki, Ferda Alpaslan Pınarlı, Süeda Hekimoğlu · 2020 · Journal of Drug Delivery Science and Technology
  87. Association of Pre-Admission Statin Use With Reduced In-Hospital Mortality in COVID-19
    Shireen Renate Chacko, Robert DeJoy, Kevin Bryan Lo, Jeri Albano, Eric Peterson, Ruchika Bhargav, Fahad Gu, Grace Salacup, Jerald Pelayo, Zurab Azmaiparashvili et al. · 2021 · The American Journal of the Medical Sciences
  88. Therapeutic Strategies Aimed at Improving Neuroplasticity in Alzheimer Disease
    María F. Colavitta, Francisco José Barrantes · 2023 · Pharmaceutics
  89. Dual effects of statins therapy in systemic lupus erythematosus and SLE-related atherosclerosis: The potential role for regulatory T cells
    Haiyan Tu, Qi Li, Shilong Xiang, Hong Fei Jiang, Youying Mao, Zhangfei Shou, Jianghua Chen · 2012 · Atherosclerosis
  90. Impact of Statins in Outcomes of Septic Patients: A Systematic Review
    António Tralhão, Vicente Cés de Souza-Dantas, Jorge I. Salluh, Pedro Manuel Sarmento Rodrigues Póvoa · 2014 · Postgraduate Medicine
  91. Atorvastatin suppresses Toll-like receptor 4 expression and NF-κB activation in rabbit atherosclerotic plaques.
    D Fang, Shuan Suo Yang, W Quan, Hongru Jia, Z Quan, Z Qu · 2014 · PubMed
  92. 14-3-3ζ Regulates Immune Response through Stat3 Signaling in Oral Squamous Cell Carcinoma
    Xinguang Han, Yongfu Han, Huifeng Jiao, Yaqiong Jie · 2014 · Molecules and Cells
  93. Influence of statins on postoperative wound complications after inguinal or ventral herniorrhaphy
    Martin Hauer‐Jensen, Charlton Fort, J. L. Mehta, Louis M. Fink · 2005 · Hernia
  94. The potential therapeutic role of statins in central nervous system autoimmune disorders
    Olaf St amp uuml ve, Sawsan Youssef, Shannon E. Dunn, Anthony Slavin, Lawrence Steinman, Scott S. Zamvil · 2003 · Cellular and Molecular Life Sciences
  95. New concepts in organ preservation
    U Nydegger, Thierry Pierre Carrel, Thomas Laumonier, Paul Mohaçsi · 2002 · Transplant Immunology
  96. Statins as immunosuppressive agents
    JON A. KOBASHIGAWA · 2001 · Liver Transplantation
  97. Combinatorial Effect of Metformin and Lovastatin Impedes T-cell Autoimmunity and Neurodegeneration in Experimental Autoimmune Encephalomyelitis
    Ajaib Singh Paintlia · 2013 · Journal of Clinical & Cellular Immunology
  98. Treatment With Simvastatin and Rifaximin Restores the Plasma Metabolomic Profile in Patients With Decompensated Cirrhosis
    Elisa Pose, Elsa Solà, Juan José Lozano, Adrià Juanola, Julia Sidorova, Giacomo Zaccherini, Koos de Wit, Frank Erhard Uschner, Marta Tonon, Konstantin Kazankov et al. · 2021 · Hepatology Communications
  99. The effects of statins on the function and differentiation of blood cells
    Sajjad Chamani, Omid Kooshkaki, Maryam Moossavi, Mandana Rastegar, Sara Saffar Soflaei, Alice Patricia McCloskey, Maciej Banach, Amirhossein Sahebkar · 2022 · Archives of Medical Science
  100. Interactions between Autophagy and Bacterial Toxins: Targets for Therapy?
    Jacques Mathieu · 2015 · Toxins